Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COBEX-PED
NCT06722118Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2025
- Primary completion
- Oct 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in upper airway obstruction (UAO) comparing Intravenous dexamethasone with Placebo (2 arms). Primary endpoint: Cumulative incidence of respiratory distress due to upper airway obstruction at 48 hours. Started Oct 2025; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
upper airway obstruction (UAO)
Beyond the preview
Go deeper on NCT06722118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06722118.